22 November 2017
News and Views
Links and Services
October's issue of the Alimentary Pharmacology & Therapeutics examines remission of refractory Crohn's disease by high-dose cyclophosphamide and autologous peripheral blood stem cell transplantation.
Despite advances in immunosuppressive therapy, up to 10% of patients with severe Crohn's disease
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors